Search Results 41-50 of 11943 for Rimegepant

  1. Alefacept (intramuscular route) - Side effects & uses - Mayo Clinic

    Alefacept injection is used to treat chronic plaque psoriasis, which is a skin disease with red and white scales that don't go away. This medicine is given to ...

  2. Simeprevir (oral route) - Side effects & dosage - Mayo Clinic

    These medicines are used in patients with liver disease (including cirrhosis) who have not been treated before or who have received other medicines that did not ...

  3. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the genetic and ...

  5. Temozolomide (intravenous route) - Mayo Clinic

    Before you begin treatment with temozolomide injection, you and your doctor should talk about the benefits this medicine will do as well as the risks of using ...

  6. A Study To Assess Change In Disease Activity And Adverse Events (AE)s In Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) As An Intravenous (IV) Infusion - Mayo Clinic

    Immunoglobulin light chain (AL) amyloidosis is the most common form of systemic amyloidosis. AL amyloidosis has many root causes and is characterized by the ...

  7. Promethazine (rectal route) - Mayo Clinic

    Promethazine is also used to prevent and control motion sickness, nausea, vomiting, and dizziness. In addition, it may be used to help people go to sleep and ...

  8. Cemiplimab-rwlc (intravenous route) - Mayo Clinic

    Cemiplimab-rwlc injection is used to treat a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread (metastatic) or cannot be cured ...

  9. Remdesivir (intravenous route) - Side effects & uses - Mayo Clinic

    Brand Name. US Brand Name · Description. Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19) in hospitalized patients. · Before Using. In ...

  10. Pembrolizumab and berahyaluronidase alfa-pmph (subcutaneous route) - Side effects & uses - Mayo Clinic

    This medicine is also used alone as first-line treatment of HNSCC in patients whose tumors express PD-L1 or patients who have received other cancer medicines ( ...